IPO Analysis Aastha Spintex IPO Review: Subscription Status, GMP & Analysis Aastha Spintex IPO 2026 opens for subscription today. Read our detailed analysis of its price band, issue size, business model, financials, strengths, risks and investor outlook.
IPO Analysis Waterways Leisure Tourism IPO Review: Subscription Status, GMP & Analysis Waterways Leisure Tourism IPO 2026 opens with muted subscription and subdued GMP. Read our detailed analysis of its price band, issue size, business model, financials, strengths, risks and investor outlook.
IPO Analysis Turtlemint Fintech Solutions IPO Review: Subscription Status, GMP & Analysis Turtlemint IPO 2026 opens with muted subscription and subdued GMP. Read our detailed analysis of its price band, issue size, business model, financials, strengths, risks and investor outlook.
SpaceX IPO 2026 SpaceX IPO, Valuation & Risks: Can It Become the Next Tesla? As SpaceX prepares for its historic public market debut under ticker SPCX, investors are weighing a $1.75 trillion valuation against core growth drivers like Starlink and orbital AI infrastructure. Is it the next Tesla, or is the starting price too high for retail investors?
IPO Analysis CMR Green Technologies IPO Review: Subscription Status, GMP & Analysis The CMR Green Technologies IPO saw strong Day 1 momentum, hitting 87% subscription by noon. Priced at ₹182–₹192, this ₹631 crore public issue is a pure offer-for-sale. Before you apply, read our quick review on its financials and risk factors.
IPO Analysis CMPDI IPO Review: Coal India’s "Technical Brain" Goes Public CMPDI IPO opens March 20, 2026. Analysis of the Rs 1,842 Crore OFS, financials and valuation. Is this Coal India "brain" a subscribe? Read now.
IPO Analysis GSP Crop Science IPO Review: Is it a Value Buy? GSP Crop Science's Rs 400-crore IPO opened today to a quiet market response. While the valuation looks attractive, rising geopolitical tensions and a weak monsoon forecast pose significant risks. Subscribe or avoid? Here is our deep-dive verdict.
IPO Review Innovision IPO Review: High Growth or High Risk? Should You Subscribe? Innovision Ltd’s IPO is off to a slow start with a 2% subscription rate as of 2 PM on Day 1. Despite an 87% revenue CAGR, legal disputes and high valuations loom large. Should you subscribe? Read our deep-dive analysis.
IPO Review Sedemac Mechatronics IPO Review: Should You Subscribe Despite High Valuation? Sedemac Mechatronics IPO is off to a slow start with a 29% subscription rate on Day 2. While SML dominates the ECU market, the steep IPO valuation raises concerns. Is this ₹1,087 Cr OFS worth the premium? Read our full analysis.
IPO Review Aye Finance IPO Review: Muted Demand—Should You Subscribe? Aye Finance IPO sees a slow start with just 17% subscription as it enters its final day. With a ₹1,010 Cr issue size, is this MSME lender a "Subscribe" or a "Wait"?
IPO Review Fractal Analytics IPO: Is India’s First AI-Centric Listing a Buy? Fractal Analytics is making history as India’s first pure-play AI enterprise to go public. With a ₹2,834 Cr issue and clients like the "Magnificent Seven," the hype is high—but do the valuations back it up?
IPO News Bharat Coking Coal IPO: In-Depth Analysis & Review Get a detailed overview of Bharat Coking Coal’s IPO, including Financial Analysis, Key Strengths, Risk Factors and Expert Verdict.
IPO Analysis Gujarat Kidney & Super Speciality IPO: In-Depth Analysis & Review Get a detailed overview of Gujarat Kidney & Super Speciality’s IPO, including Financial Analysis, Key Strengths, Risk Factors and Expert Verdict.
IPO Analysis KSH International IPO: In-Depth Analysis & Review Get a detailed overview of KSH International’s IPO, including Financial Analysis, Key Strengths, Risk Factors and Expert Verdict.
IPO Analysis ICICI Prudential AMC IPO: Hype, Fundamentals & Valuation Get a detailed overview of ICICI Prudential AMC’s IPO, including Financial Analysis, Key Strengths, Risk Factors and Expert Verdict.
IPO Review Could Meesho’s IPO Be Your Next Big Investment Opportunity? Get a detailed overview of Meesho’s IPO, including Financial Analysis, Key Strengths, Risk Factors and Expert Verdict.
IPO Analysis Sudeep Pharma IPO: A Growing Player in Pharma, But Is It a Safe Bet? Get a detailed overview of Sudeep Pharma IPO, including Financial Analysis, Key Strengths, Risk Factors and Expert Verdict.
IPO Analysis EdTech Meets SaaS: Is Excelsoft IPO Ready for the Big League? Get a detailed overview of Excelsoft Technologies IPO, including Financial Analysis, Key Strengths, Risk Factors and Expert Verdict.
IPO Analysis Could Tenneco's IPO Be Your Next Big Investment Opportunity? Get a detailed overview of Tenneco Clean Air India’s IPO, including Financial Analysis, Key Strengths, Risk Factors and Expert Verdict.
IPO Analysis EdTech Firm PhysicsWallah’s Rs 3,480-Cr IPO — Subscribe or Avoid? Get a detailed overview of PhysicsWallah’s IPO, including Financial Analysis, Key Strengths, Risk Factors and Expert Verdict.
IPO Review India’s Largest Broking IPO: Groww’s Rs 6,600-Cr Offering — Subscribe or Avoid? Get a detailed overview of Groww’s IPO, including Financial Analysis, Key Strengths, Risk Factors and Expert Verdict.
IPO Analysis Lenskart IPO: Sky-High Valuations But Huge Buzz—Should You Dive In? Get a detailed overview of Lenskart Solutions’ IPO, including Financial Analysis, Key Strengths, Risk Factors and Expert Verdict.
IPO Review Helmet Maker’s IPO Ride: Should You Strap In or Sit This One Out? Get a detailed overview of Studds Accessories’ IPO, including Financial Analysis, Key Strengths, Risk Factors and Expert Verdict.
IPO Review Can Orkla India’s IPO Add Flavour to Your Portfolio? Get a detailed overview of Orkla India‘s IPO, including Financial Analysis, Key Strengths, Risk Factors and Expert Verdict.
IPO Review Midwest’s IPO is LIVE — Evaluate Before You Act Get a detailed overview of Midwest’s IPO, including Financial Analysis, Key Strengths, Risk Factors and Expert Verdict.
